The antagonists of appetite-stimulating factors such as ghrelin, which inhibits appetite-stimulating neurons such as Npy/AgRP in the hypothalamus, were found to result in a variety of cachexia symptoms, such as loss of appetite, weight loss, and muscle atrophy in advanced cancer patients [134]. This evidence concerns the gene GHRL and cancer.